Document Type : Editorial article
Author
Department of Surgery/Otolaryngology, College of Medicine, University of Anbar, Ramadi, Anbar, Iraq
Abstract
The COVID-19 infection is caused by SARS-CoV-2 and it is considered by the WHO as a pandemic disease since February 2020. It is still an evolving disease, with new symptoms being discovered as time progress. A peculiar and interesting symptoms that has been frequently investigated by researchers across the globe are anosmia (loss of smell) and ageusia (loss of taste), as some subjects complain of diminution in the sense of smell and taste. Moreover, these symptoms may be the only or first clinical findings of the disease. Therefore, it is of utmost importance to isolate at home the individuals with recent smell and taste abnormalities (STA) without any other features of COVID-19 to prevent the transmission of the infection to healthy people [1].
Keywords
Main Subjects
[3] C. H. Yan, F. Faraji, D. P. Prajapati, C. E. Boone, and A. S. DeConde. Association of chemosensory dysfunction and covid19 in patients presenting with influenzalike symptoms. in International Forum of Allergy & Rhinology, 2020.
infection. medRxiv, 2020.
1{11, 2020.
2020.
suspected covid-19. Eur. Arch. Oto-Rhino-Laryngology, pages 1-2, 2020.
dysfunction: a biomarker for covid19. International Forum of Allergy and Rhinology, 2020.
579(7798):270-273, 2020.
patients with primary hypertension. Acta Pol Pharm, 69(1):121{127, 2012.